![Mats Blom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mats Blom
Président chez
EGETIS THERAPEUTICS AB
Fortune : 2 M $ au 31/05/2026
Profil
Mr. Mats Blom is a Chairman at Egetis Therapeutics AB, an Independent Director at Hansa Biopharma AB and an Independent Non-Executive Director at Altamira Therapeutics Ltd. He is on the Board of Directors at Pephexia Therapeutics ApS, Hansa Biopharma AB, Altamira Therapeutics Ltd. and Auris Medical AG.
Mr. Blom was previously employed as a Chief Financial Officer by NorthSea Therapeutics BV, a Chief Financial Officer by Modus Therapeutics AB, an Independent Non-Executive Director by Auris Medical Holding AG /Old/, a Chief Financial Officer & Executive Vice President by Zealand Pharma A/S, a Chief Financial Officer by Swedish Orphan International Holding AB, a Chief Financial Officer by Anoto Group AB, a CFO & Vice President-Business Development by Active Biotech AB, and a Chairman by Immedica Pharma AB. He received his undergraduate degree from the University of Lund and an MBA from the Instituto de Estudios Superiores de la Empresa.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EGETIS THERAPEUTICS AB 0,75 % | 31/12/2025 | 3 499 762 ( 0,75 % ) | 2 M $ | 31/05/2026 |
| 31/12/2025 | 1 000 ( 0 % ) | 3 650 $ | 31/05/2026 | |
| 15/04/2025 | 0 ( -.--% ) | - $ | 31/03/2026 |
Postes actifs de Mats Blom
| Sociétés | Poste | Début |
|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Directeur/Membre du Conseil | 01/04/2017 |
| HANSA BIOPHARMA AB | Directeur/Membre du Conseil | 22/05/2019 |
| EGETIS THERAPEUTICS AB | Président | 06/05/2024 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Directeur/Membre du Conseil | - |
Pephexia Therapeutics ApS | Directeur/Membre du Conseil | 01/10/2020 |
Anciens postes connus de Mats Blom
| Sociétés | Poste | Fin |
|---|---|---|
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Directeur Financier/CFO | 20/02/2025 |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Directeur Financier/CFO | 15/03/2021 |
| ZEALAND PHARMA A/S | Directeur Financier/CFO | 31/03/2019 |
Swedish Orphan International Holding AB
 Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products and drugs | Directeur Financier/CFO | 03/06/2010 |
| ░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░ ░░░░░░░░░ ░ ░░░ ░░░ | ░░░░░░░░░░ |
Formation de Mats Blom
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Anoto Group AB
 Anoto Group AB Computer PeripheralsElectronic Technology Manufactures and distributes smart pens & develops software-as-a-service platform | Electronic Technology |
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products and drugs | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
Instituto de Estudios Superiores de la Empresa
 Instituto de Estudios Superiores de la Empresa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Health Technology |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
Auris Medical Holding AG /Old/
 Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Health Technology |
Altamira Therapeutics Ltd.
 Altamira Therapeutics Ltd. BiotechnologyHealth Technology Develops RNA therapeutics for inner ear disorders | Health Technology |
Pephexia Therapeutics ApS |
